Imposing a rebate in the U.S. that is based on drug prices outside the U.S. would mark a drastic and unprecedented shift in the U.S. pharmaceutical market, and while the impact of the Globe and Guard proposed regulations, if finalized, cannot yet be determined, it is likely to be significant.
All entries for: Aligos Therapeutics, Inc.
May 7, 2026
Aligos Therapeutics, Inc.
Neutral Outlook
South San Francisco, CA
51-200 employees
The impact of the IRA on us and the pharmaceutical industry cannot yet be fully determined, but is likely to be significant.
Disease Area: Chronic Disease, Infectious Diseases, Metabolic Diseases
Drug Type: Small Molecule